These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1937123)

  • 1. [Pharmacologic management of dysfunctional uterine hemorrhage].
    Walss Rodriguez R; Ramírez Alverde A
    Ginecol Obstet Mex; 1991 Jun; 59():192-4. PubMed ID: 1937123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysfunctional uterine bleeding. Hormonal management with chlormadinone acetate].
    Olivas Mendoza G; Santos Martínez A; Corral Olaguez M; Iduñate y Carlos DM; Hernández Ayup S
    Ginecol Obstet Mex; 1978 Dec; 44(266):463-71. PubMed ID: 84774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study.
    DeVore GR; Owens O; Kase N
    Obstet Gynecol; 1982 Mar; 59(3):285-91. PubMed ID: 6281704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal uterine bleeding.
    Connell A
    Nurse Pract; 1989 Apr; 14(4):40, 43-4, 47 passim. PubMed ID: 2652003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal bleeding in adolescents.
    Gidwani GP
    J Reprod Med; 1984 Jun; 29(6):417-20. PubMed ID: 6747972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of dysfunctional uterine bleeding and its conservative management.
    Siddiqui SH
    J Coll Physicians Surg Pak; 2003 Jul; 13(7):375-7. PubMed ID: 12887835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dysfunctional uterine bleeding in the adolescent].
    Bourque J; Gaspard U; Bourguignon JP; Lambotte R
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):173-84. PubMed ID: 3722744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the role of incidental diagnostic dilation and curettage in young women undergoing elective laparoscopic sterilization.
    Varaklis K; Stubblefield PG
    J Reprod Med; 1995 Jun; 40(6):415-7. PubMed ID: 7650651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytohistologic correlation in patients with clinical symptoms of postmenopausal bleeding.
    Webster SD; Cason Z; Lemos LB; Benghuzzi H
    Biomed Sci Instrum; 2000; 36():367-72. PubMed ID: 10834260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we decrease breakthrough bleeding in patients with endometriosis on norethindrone acetate?
    Muneyyirci-Delale O; Jalou S; Rahman M; Nacharaju V
    Int J Fertil Womens Med; 2003; 48(1):32-6. PubMed ID: 12643518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine instillation of trichloroacetic acid is effective for the treatment of dysfunctional uterine bleeding.
    Kucuk M; Okman TK
    Fertil Steril; 2005 Jan; 83(1):189-94. PubMed ID: 15652906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making sense of dysfunctional uterine bleeding.
    Johnson CA
    Am Fam Physician; 1991 Jul; 44(1):149-57. PubMed ID: 2058529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effectiveness of norethindrone-mestranol in dysfunctional uterine bleeding].
    Reyes Ceja L; Zarate A; Guerrero A
    Ginecol Obstet Mex; 1968 Jan; 23(135):103-7. PubMed ID: 5674323
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of hysteroscopic findings and histologic diagnoses in patients with abnormal uterine bleeding.
    Lasmar RB; Dias R; Barrozo PR; Oliveira MA; Coutinho Eda S; da Rosa DB
    Fertil Steril; 2008 Jun; 89(6):1803-7. PubMed ID: 17889860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial treatment of dysfunctional uterine bleeding with estrogen--progestin combination.
    Mansuwan K
    J Med Assoc Thai; 1980 Jan; 63(1):6-10. PubMed ID: 7359057
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysfunctional uterine bleeding.
    Smith CB
    Am Fam Physician; 1987 Sep; 36(3):161-8. PubMed ID: 3630881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term investigation and therapeutic results in women with dysfunctional uterine bleeding (author's transl)].
    Horský J; Vreclová S; Presl J
    Cesk Gynekol; 1973 Sep; 38(8):621-3. PubMed ID: 4797245
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
    Hawe J; Abbott J; Hunter D; Phillips G; Garry R
    BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.